UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
WHWK
Whitehawk Therapeutics Inc
There isn't enough reported data to score WHWK yet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
WHWK Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Unavailable | |
| Unavailable |
WHWK's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | โ |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | โ |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
WHWK PE Valuation
WHWK has no meaningful PE right now: it lost money over the past year.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
WHWK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| -- | |
| -- | |
| Limited | |
| Low |
Analysts expect WHWK's losses to shrink, with revenue holding steady. However, they disagree widely on these estimates.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over WHWK on earnings quality, reporting a profit while its opponent remains loss making.
WHWK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.89 | -1554% |
| Q2 2026 | -$1.92 | -$1.85 |
| Q1 2026 | -$2.48 | -1753% |
| Q4 2025 | -$0.33 | +$2.03 |
| Q3 2025 | $0.13 | +$2.41 |
| Q2 2025 | -$0.07 | +$2.35 |
| Q1 2025 | $0.15 | +$2.70 |
| Q4 2024 | -$2.36 | +$0.08 |
WHWK has swung to a loss: it lost $1.89 per share over the past year, after a profit the year before.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over WHWK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
WHWK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2025 | $7.1M | +33% |
| Q4 2024 | $7.2M | +14% |
| Q3 2024 | $7.2M | +21% |
| Q2 2024 | $6.2M | -0.4% |
| Q1 2024 | $5.4M | -8.8% |
| Q4 2023 | $6.3M | +21% |
| Q3 2023 | $6M | +40% |
| Q2 2023 | $6.2M | +80% |
WHWK's revenue has slid since its 2020 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2025 | -213% | +152 points |
| Q4 2024 | -262% | +18 points |
| Q3 2024 | -186% | +114 points |
| Q2 2024 | -252% | +63 points |
| Q1 2024 | -365% | -78 points |
| Q4 2023 | -280% | +16 points |
| Q3 2023 | -300% | +55 points |
| Q2 2023 | -315% | +219 points |
WHWK's operating margin was โ213% last quarter, up 152 points from the same quarter a year ago.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over WHWK on cash generation, producing positive trailing cash flow while its opponent burns cash.
WHWK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$19.7M | -$4.3M |
| Q2 2026 | -$14.5M | +$38.4M |
| Q1 2026 | -$22.2M | -$9.8M |
| Q4 2025 | -$17.2M | -$2M |
| Q3 2025 | -$15.4M | +$497K |
| Q2 2025 | -$53M | -$43.3M |
| Q1 2025 | -$12.4M | +$8M |
| Q4 2024 | -$15.2M | -$4.8M |
WHWK has burned cash in almost every quarter: โ$74M over the past year, against โ$96M the year before.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
WHWK Net Leverage
WHWK's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
WHWK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.5 | Neutral |
| Stochastic | 13.2 | Oversold |
WHWK's weekly RSI is 40 (neutral) and its Stochastic is 13 (oversold).
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
WHWK PE vs Healthcare Sector
| Metric | WHWK | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | โ |
WHWK has no meaningful PE right now: it lost money over the past year.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over WHWK on trend strength, trading above more of its moving averages.
WHWK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.31 | 7.3% below |
| 20 week MA | $3.88 | 21% below |
| 50 week MA | $3.63 | 15% below |
| 100 week MA | $2.89 | 6.2% above |
| 200 week MA | $3.60 | 15% below |
WHWK's trend is mixed: it's above one of its five weekly moving averages, and 15% below its 200-week average.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over WHWK on returns for 2026, with the stronger performance.
WHWK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $26.0 | $25.9 | -0.6% |
| 2022 | $25.9 | $12.5 | -52% |
| 2023 | $12.5 | $2.02 | -84% |
| 2024 | $2.02 | $3.21 | +59% |
| 2025 | $3.21 | $2.67 | -17% |
| 2026 YTD | $2.67 | $3.07 | +15% |
WHWK has finished lower in four of the last five years. It's up 15% so far in 2026.